Day: September 26, 2024

PodcastOne (PODC) Debuts Beat It Out Podcast from Adam Carolla Exclusively on Adam Carolla Show Substack Beat It Out is the 46th Show Added to PodcastOne in 2024, Expands Partnership with Network Tentpole Host Carolla First Season of Beat It Out Features Co-Host, Comedian Jay Mohr Carolla’s All Time Downloads Top 700 Million LOS ANGELES, Sept. 26, 2024 (GLOBE NEWSWIRE) — PodcastOne, (Nasdaq: PODC) a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), announced today the launch of Beat It Out, a podcast from Podcasting Hall of Fame member Adam Carolla exclusively on the Adam Carolla Show Substack featuring Season One co-host, comedian Jay Mohr. The addition of Beat It Out to the network’s roster of podcast programming further strengthens the 15 years long relationship between PodcastOne and Carolla who has been...

New Gaxos Labs AI Solution Offers Developers a Suite of Tools to Increase Revenue, Accelerate Development, Empower Creativity and Enrich User ExperiencesA Media Snippet accompanying this announcement is available by clicking on this link. ROSELAND, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today revealed the official launch of Gaxos Labs, its cutting-edge artificial intelligence solution for game developers and publishers. Gaxos Labs empowers game developers to accelerate the development process, enhance creativity and increase revenue through its proprietary generative AI asset editor and Unity plugin, and player-facing generative AI offering. By utilizing Gaxos Labs, developers can...

Detroit, Sept. 26, 2024 (GLOBE NEWSWIRE) — DTE Energy (NYSE:DTE), Michigan’s largest producer of and investor in renewable energy, today announced that it has broken ground on three new solar parks in the last four months, in response to growing customer support for clean, renewable energy. The Fish Creek and Mission Road solar parks, located in mid-Michigan, and the Little Trout Solar Park, located in northern Michigan, are all funded by customers who voluntarily enrolled in DTE’s CleanVision MIGreenPower program. In addition to the three solar parks referenced above, three other solar parks funded through MIGreenPower are currently under construction. Together, all six developments will add 800 megawatts to DTE’s renewable energy portfolio, enough to power more than 220,000 homes. These solar developments are yet another step...

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today it will issue its financial results for the three and nine months ended September 30, 2024 after markets close on: Thursday, November 7, 2024 A conference call to discuss the results will be hosted by the CAPREIT senior management team on: Friday, November 8, 2024 at 9:00 am ET The telephone numbers for the conference call are: Canadian Toll Free: +1 (833) 950-0062International: +1 (929) 526-1599Access Code: 250284 The call will also be webcast live and accessible through the CAPREIT website at www.capreit.ca – click on “For Investors” and follow the link at the top of the page. A replay of the webcast will be available for one year after the webcast at the same link. The slide presentation...

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES”) (TSX:ERE.UN) announced today it will issue its financial results for the three and nine months ended September 30, 2024 after markets close on: Wednesday, November 6, 2024 A conference call to discuss the results will be hosted by the ERES senior management team on: Thursday, November 7, 2024 at 9:00 am ET The telephone numbers for the conference call are: Canadian Toll Free: +1 (833) 950-0062 International: +1 (929) 526-1599 Access Code: 217681 The call will also be webcast live and accessible through the ERES website at www.eresreit.com – click on “Investor Info” and follow the link at the top of the page. A replay of the webcast will be available for one year after the webcast at the same link. The slide presentation...

Teledyne DALSA’s BOA3 smart cameraBOA3 smart cameras offer unmatched flexibility and functionality for quick, cost-effective machine vision deploymentsBOSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Teledyne DALSA, a Teledyne Technologies [NYSE:TDY] company and global leader in machine vision technology, is pleased to announce its next generation AI-powered BOA™3 smart camera for industrial automation and inspection. The new BOA3 smart camera is designed to leverage the best features from previous BOA generations and combine them with new sensor and AI (Artificial Intelligence) inspection technologies developed by Teledyne. BOA3 is a highly integrated vision system in a compact, rugged smart camera format designed to meet the needs of the most complex, demanding machine vision applications. “The new BOA3 is an exciting...

NOVATO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it will present seven abstracts related to its ongoing late-stage program evaluating setrusumab (UX143) and osteogenesis imperfecta (OI), including a late-breaker oral presentation of the 14-month data from the Phase 2/3 Orbit study, at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting. The meeting is being held September 27-30, 2024, in Toronto, Canada. “Presentations at this year’s ASBMR meeting add to our growing knowledge of the real-world impact and burden of OI and underscore the urgent need for an innovative therapy for these patients,” stated Eric Crombez, M.D., chief medical officer at Ultragenyx. “We will also present the phase 2 Orbit study results that we previously announced...

BOCA RATON, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) —  INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology and inflammation company, continues to advance its Natural Killer (NK) cell therapy, INKmune™, in a Phase I/II trial (the “CaRe PC” trial) for men with metastatic Castration-Resistant Prostate Cancer (mCRPC). The Company is pleased to announce initial results from the first patient cohort in the trial. Mark Lowdell, CSO and inventor of INKmune™, said, “The enrollment of the first cohort ran entirely in-line with our predicted timelines and confirmed the excellent safety profile with all patients receiving treatment as out-patient without the need for pre-medication of any kind. Furthermore, even at this lowest dose of INKmune™, there is clear evidence of persistent immunologic...

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced the appointment of John Louis Fouts to its Board of Directors (“Board”), effective September 23, 2024. “We’re excited to welcome Lou to the Board,” said Jeff Gendell, IES’s Chairman and CEO. “Lou brings an extensive background in investment management and finance, and I’m confident that his knowledge, experience and perspective will make him a valuable addition to our Board.” Mr. Fouts has served as the managing member at Fouts Family Investments, a private investment holding company, since 2021. He also currently serves as a Trustee of the Georgia Tech Foundation and is the Chairman of its Investments Committee. From 2002 to 2021 he was a partner with Water Street Capital, Inc., a private investment firm located...

— Poster to be presented at ACR Convergence annual meeting — TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the upcoming presentation of new data in support of its gene therapy candidate, PCRX-201 (enekinragene inzadenovec). The data will be presented at the American College of Rheumatology’s annual ACR Convergence meeting, being held in Washington, D.C. November 14–19. Presentation Title: Sustained Clinical Effects After a Single Intra-articular Injection of PCRX-201 for Moderate-to-Severe Osteoarthritis of the Knee Presented By: Stanley Cohen, MD, a board-certified rheumatologist and Co-Medical Director of the Metroplex Clinical Research Center in Dallas, TX Date & Time: Sunday,...